A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
Emily M. Ploeg(University Medical Center Groningen), Wijnand Helfrich(University Medical Center Groningen)
Cited by 5
Related Papers
Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists
|Cancer Research|2008|46
Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
|Journal of Molecular Medicine|2008|30
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
|Molecular Oncology|2020|15